HOME >> MEDICINE >> NEWS
Men more at risk of recurrent blood clots than women

Men have a 50% higher relative risk of suffering from recurrent blood clots after a first episode than women, according to an article in this week's issue of The Lancet. The baseline frequency of recurrent blood clots is 25% after five years.

Dr Simon McRae from the Department of Haematology (Queen Elizabeth Hospital, Woodville, South Australia, Australia) and his colleagues from the Department of Medicine, McMaster University (Hamilton, Ontario, Canada) did a meta-analysis of studies involving both men and women who were being treated for either deep vein thrombosis or pulmonary embolism (in which a clot detaches from a deep vein and lodges in the lung). They looked at rates of recurrence of blood clots in patients after they had stopped taking preventative anticoagulant (blood-thinning) medication.

A total of 5416 patients were enrolled in 15 eligible studies, 50% were men and 50% women. There were 816 recurrent blood clots, of which 523 (64%) were in men and 293 (36%) were in women.

The cause of heightened risk in men is unclear, but the authors state it could be attributable to differences in age, body mass index, or inherited susceptibility to blood clots. Dr Simon McRae writes: "further prospective studies are needed before a firm recommendation can be made to incorporate patient sex into decision making on duration of anticoagulant treatment in individual patients."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
27-Jul-2006


Page: 1

Related medicine news :

1. Vorinostat shows anti-cancer activity in recurrent gliomas
2. New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer
3. Popular statin reduces recurrent stroke risk
4. Measurement of urinary protein can help detect recurrent bladder cancer
5. Point-of-care test proves more effective for recurrent bladder cancer than conventional lab test
6. Antibiotics do not prevent recurrent myocardial infarcts in subjects with periodontitis
7. Study suggests mechanism for recurrent sudden infant death syndrome
8. Biomarkers may provide important information for patients at risk for recurrent ischemic stroke
9. Treatment regimen offers greater survival advantage for recurrent head and neck cancers
10. Biomarkers used to predict recurrent disease in hepatitis C transplant patients
11. Antidepressants may lower risk of recurrent heart attack in depressed heart attack patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Men more risk recurrent blood clots than women

(Date:5/23/2013)... 2013 Cheap Concert Tickets announces that ... 2013 at stadiums throughout North America. This well known ... McCartney concert tickets to help McCartney fans see Sir Paul ... Tickets, states that she is also offering the customer appreciation ... Being a baby boomer, she is also a huge McCartney ...
(Date:5/23/2013)... News) -- Schools should ensure that kids get ... day to support their health and boost performance ... Although previous studies show 60 minutes of ... development, it,s estimated that only about 50 percent ... according to the report from the Institute of ...
(Date:5/23/2013)... 23 (HealthDay News) -- Symptoms of borderline personality ... complicating diagnosis and treatment. But researchers in Canada ... be unique to borderline personality disorder: a tendency ... , "They have difficulty processing facial emotions and ... face," said Anthony Ruocco, a clinical neuropsychologist and ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay ... teeth as badly as methamphetamine or crack cocaine, a ... with ,meth mouth, or ,coke mouth, it is startling ... or less the same," said Dr. Mohamed Bassiouny, a ... of Dentistry in Philadelphia. Methamphetamine, crack cocaine and ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Although a ... reverse the thinking and memory problems associated with ... they have been unable to duplicate those findings. ... serious implications for patient safety since the drug ... side effects, such as major blood-lipid abnormalities, pancreatitis, ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2
(Date:5/23/2013)... , May 23, 2013  Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...
(Date:5/23/2013)... May 23, 2013 Isis Pharmaceuticals, Inc. (NASDAQ: ... that management will present a company overview at the Deutsche ... Thursday, May 30, 2013 at 8:40 a.m. ET in ... webcast of the presentation will be available on the "Investors ... .  A replay will be available on the Isis Web ...
(Date:5/23/2013)... -- InspireMD, Inc. ("InspireMD" or the ... protection stents, today announced new 6-month results from ... trial demonstrating that the MGuard Embolic Protection Stent ... in all-cause mortality in ST segment elevation myocardial ... presented at the InspireMD STEMI Symposium at EuroPCR, ...
Breaking Medicine Technology:Cardinal Health Selects Datameer for Healthcare Data Discovery 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
Cached News: